Notice/News
Notice/News
Number
Title
Date
1
[MoneyToday] MoneyToday Power Interview
2025.12.26
2
[Notice] CRISPR RNP Patent Status(US,EU)
2025.12.24
3
[Press Release] ToolGen Receives Intention to Grant for European ‘CRISPR RNP’ Patent… Vertex’s Attempt to Block Overturned
2025.12.10
4
[Press Release] ToolGen Successfully Defends European CRISPR RNP Plant Patent… “An Unprecedented Outcome Overturning Preliminary Decision”
2025.12.03
5
[Press Release] ToolGen and GenEditBio Sign Strategic Cross-License Agreement… Accelerating Co-Development of Innovative Gene-Editing Therapies
2025.11.24
6
[Overseas Press Release ] ToolGen and GenEditBio Enter Strategic Cross-License Agreement to Accelerate Development of Innovative Genome-Editing Therapeutics
2025.11.24
7
[Press Release] ToolGen Completes U.S. Patent Registration for CRISPR Cas9 RNP Core Technology… Files U.S. Lawsuit Related to CASGEVY®
2025.11.19
8
[Overseas Press Release] ToolGen Completes U.S. Patent Registration for Core CRISPR Cas9 RNP Technology; Files U.S. Lawsuit Related to CASGEVY®
2025.11.19
9
[Notice] U.S. Patent Registration Certificate (CRISPR RNP)
2025.11.18
10
[Press Release] ToolGen Signs CRISPR-Cas9 Technology Transfer Agreement with Abinogen
2025.11.06
11
[The Bio] CRISPR-Cas9 Foundational Patent Invalidated in China’s First Trial—CVC Group Loses… ToolGen Smiles
2025.09.30
12
[Press Release] ToolGen Selected for ‘Korean ARPA-H’ Project… Developing Gene-Editing Therapy for Rare Hereditary Retinal Diseases in Korea and Japan
2025.09.10
13
[Press Release] ToolGen Files Patent Infringement Lawsuit Against Lonza in the Netherlands
2025.09.08
14
[Overseas Press Release] ToolGen Files Patent Infringement Lawsuit Against Lonza in the Netherlands
2025.09.08
15
[Hankyung BIO Insight] ToolGen, Holder of CRISPR-Cas9 Foundational Patent, Targets Therapeutics and Seeds with Technological Edge
2025.08.19